Former Operation Warp Speed chief Moncef Slaoui, who GlaxoSmithKline fired last year because of a sexual harassment claim, is returning $3.86 million to the company, according to its annual executive compensation report.
Slaoui, who was chairman of the board of GSK’s Galvani Bioelectronics when he was dismissed in March 2021, agreed to the cash return as the company applied “clawback provisions" under its “recoupment policy.”
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,